A profound experience can change the way someone sees their life.
But seeing life differently and living differently are not the same thing.
This distinction is central to the way we approach treatment at Inner Realms Center.
IRC works specifically with ibogaine and 5-MeO-DMT.
These two substances can involve very different experiences and they do not occupy identical roles within our treatment model.
What they do share is an important reality:
The experience itself is only one part of the process.
Preparation comes before it.
Clinical responsibility surrounds it.
Integration follows it.
And ultimately, the participant returns to everyday life.
That is where many of the most important changes must actually be lived.
Recovery is more than a single moment
Recovery is sometimes imagined as a turning point.
There may indeed be turning points.
A person may stop using a substance.
They may recognize patterns they had never previously understood.
They may experience a powerful change in perspective.
They may reconnect with aspects of themselves that had felt inaccessible.
But recovery does not end at the moment of realization.
The next question becomes:
What changes in everyday life because of what was experienced?
That distinction is essential when discussing both ibogaine and 5-MeO-DMT.
The role of ibogaine at Inner Realms Center
Ibogaine forms the central treatment component of IRC’s ibogaine programs.
People may seek ibogaine treatment for different reasons, including substance dependence and complex emotional or behavioral patterns.
Because ibogaine produces significant physiological effects and carries known medical risks, treatment begins well before administration.
Candidates complete a clinical pre-assessment.
Bloodwork and an ECG are required.
Medical history and test results are reviewed before a candidate proceeds through the treatment process.
Preparation conversations also begin before arrival.
These conversations are designed to better understand the individual rather than simply the condition or problem that brought them to treatment.
A medical protocol can tell us a great deal about physiology.
It cannot tell us everything about the person living inside that physiology.
Both matter.
The role of 5-MeO-DMT at IRC
5-MeO-DMT is also part of the work conducted at Inner Realms Center, but it should not be understood simply as another version of ibogaine.
The substances are different.
Their duration is different.
Their subjective effects can be very different.
And their role within an individual’s process may also differ.
At IRC, 5-MeO-DMT is not automatically added to an ibogaine program.
Its use is considered separately within the context of the individual participant and the broader process.
This matters because treatment should not become a collection of experiences pursued simply because more is assumed to be better.
More intensity does not automatically mean more healing.
The relevant question is whether an intervention has a meaningful and responsible place in that person’s process.
A powerful experience is not automatically a transformed life
One of the central ideas behind our approach is the distinction between experience and integration.
During ibogaine or 5-MeO-DMT treatment, someone may encounter powerful emotions, memories, insights or shifts in perspective.
The experience may feel significant.
But eventually it ends.
Then daily life resumes.
Relationships remain.
Family dynamics return.
Work returns.
Financial pressures return.
Responsibilities return.
Triggers may return.
And sometimes the same environment that contributed to the person’s difficulties is still waiting for them.
This is why treatment cannot be measured only by what happens during the experience itself.
What does integration mean after ibogaine or 5-MeO-DMT?
At its simplest, integration means working with what emerged during the experience and determining how it relates to ordinary life.
For example, someone may recognize during treatment that a particular relationship has become destructive.
That recognition may occur quickly.
Changing the relationship can take much longer.
Someone may understand the emotional role a substance has played in their life.
But developing different responses to stress, isolation or fear requires repeated practice.
Someone may feel deeply connected to themselves during an experience.
The longer task may be learning how to maintain a healthier relationship with themselves during an ordinary Tuesday afternoon.
This is the difference between insight and implementation.
The experience can reveal something.
Integration asks what happens with that knowledge.
Why preparation matters before the experience
Preparation is important precisely because ibogaine and 5-MeO-DMT should not be approached as isolated events.
At IRC, preparation begins before participants arrive in Mexico.
For ibogaine candidates, medical evaluation is essential.
But preparation also considers questions that cannot be answered by an ECG or blood test.
Why is the person seeking treatment now?
What do they expect from ibogaine or 5-MeO-DMT?
Are they expecting one experience to solve every difficulty in their life?
What support exists when they return home?
What patterns or environments may need to change afterward?
These questions do not determine what someone will experience.
They help place the experience within a larger context.
Why medical oversight is central to ibogaine treatment
Ibogaine requires particular attention to medical safety.
At IRC, the personal nature of the treatment experience exists alongside structured clinical oversight.
Dr. Sue Nielsen contributes to the medical review process before treatment.
During the ibogaine flood dose, Dr. Michelle Escorza is onsite providing physician oversight.
A dedicated nurse remains present.
Cardiac telemetry is continuous.
Vital signs are monitored throughout.
Emergency response resources are available.
Garyth Moxey, IRC’s Clinical Director and Lead Provider, oversees the broader treatment process.
The purpose of this structure is not to make a deeply personal experience feel clinical.
It is to recognize that ibogaine’s medical risks require appropriate clinical responsibility.
Human care and medical rigor are not opposites.
They should reinforce one another.
Why Inner Realms Center remains deliberately small
Inner Realms Center operates with a limited number of participants.
This is intentional.
Blair Bromley, IRC’s Founder and Program Director, helped develop the center around a model in which the team can remain closely involved throughout the participant’s stay.
Garyth Moxey directs the clinical treatment process, while medical and therapeutic professionals contribute at different stages.
Keeping the model small allows preparation, treatment and integration to remain connected rather than functioning as separate services.
For the participant, the process becomes:
assessment → preparation → treatment → recovery → integration → return home → follow-up
The substance is important.
But it sits inside a much larger structure.
Recovery often involves contradiction
Recovery does not always fit into simple categories.
Someone may be stronger while still needing help.
They may become more independent while learning to accept support.
They may have undergone an extraordinary experience while still having ordinary problems.
They may understand themselves differently while still occasionally repeating an old pattern.
They may make significant progress without becoming perfect.
These realities do not necessarily mean treatment has failed.
They reflect the complexity of human change.
This is one reason we believe that presenting ibogaine or 5-MeO-DMT as a single transformational event can be misleading.
Transformation may begin with an experience.
Living that transformation is a longer process.
The treatment does not end when the experience ends
At IRC, integration support begins onsite and continues after participants return home.
That period is important because insights are eventually tested in ordinary life.
Can the participant respond differently to stress?
Can they establish healthier boundaries?
Can they recognize old patterns earlier?
Can they ask for help when they need it?
Can they build routines and relationships that support the direction they want their life to take?
These are not questions that ibogaine or 5-MeO-DMT can answer on someone’s behalf.
The participant must eventually live the answers.
Ibogaine and 5-MeO-DMT are tools within a larger human process
At Inner Realms Center, we believe it is important to avoid both extremes.
Ibogaine and 5-MeO-DMT should not be dismissed simply because their mechanisms and experiences are complex.
But they should not be presented as magical solutions either.
The substances matter.
The person matters.
Medical screening matters.
Preparation matters.
The treatment environment matters.
Integration matters.
And the choices made after treatment matter.
An experience may create an opening.
But an opening is not the same thing as a completed journey.
Recovery is what someone begins building on the other side.
Considering Ibogaine or 5-MeO-DMT Treatment?
Inner Realms Center works specifically with ibogaine and 5-MeO-DMT in Cuernavaca, Mexico.
Because these treatments require individual assessment and are not appropriate for everyone, the first step is determining which, if any, pathway may be appropriate for the individual.
For ibogaine treatment, medical screening includes clinical assessment, required bloodwork and ECG review before treatment eligibility is determined.
Request Your Clinical Assessment
Inner Realms Center
Cuernavaca, Morelos, Mexico
This article is for educational purposes and does not constitute medical advice. Ibogaine carries significant medical risks and requires appropriate screening and medical oversight. Individual responses to ibogaine and 5-MeO-DMT vary and treatment outcomes cannot be guaranteed.